Literature DB >> 34107248

Deletion of lncRNA XACT does not change expression dosage of X-linked genes, but affects differentiation potential in hPSCs.

Nami Motosugi1, Chisa Okada2, Akiko Sugiyama1, Tomoyuki Kawasaki3, Minoru Kimura4, Takashi Shiina1, Akihiro Umezawa3, Hidenori Akutsu3, Atsushi Fukuda5.   

Abstract

Female human pluripotent stem cells (hPSCs) regularly show erosion of X chromosome inactivation featured by the loss of the long non-coding (lnc) RNA XIST and the accumulation of lncXACT. Here, we report that a common mechanism for the initiation of erosion depends on XIST loss but not XACT accumulation on inactive X chromosomes. We further demonstrate that XACT deletion does not affect X-linked gene dosage in eroded hPSCs and that aberrant XIST RNA diffusion induced by the CRISPR activation system is independent of the presence of XACT RNA. In contrast, the deletion of XACT results in the upregulation of neuron-related genes, facilitating neural differentiation in both male and eroded female hPSCs. XACT RNA repression by CRIPSR inhibition results in the same phenotype. Our study finds that XACT is dispensable for maintaining the erosion of X-lined gene repression on inactive X chromosomes but affects neural differentiation in hPSCs.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Lnc RNA; X-chromosome inactivation; human pluripotent stem cell; neuron

Mesh:

Substances:

Year:  2021        PMID: 34107248     DOI: 10.1016/j.celrep.2021.109222

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  2 in total

1.  Silencing XIST on the future active X: Searching human and bovine preimplantation embryos for the repressor.

Authors:  Melis A Aksit; Bo Yu; Bernard A J Roelen; Barbara R Migeon
Journal:  Eur J Hum Genet       Date:  2022-05-19       Impact factor: 4.246

2.  X Chromosome Inactivation Timing is Not eXACT: Implications for Autism Spectrum Disorders.

Authors:  Janine M LaSalle
Journal:  Front Genet       Date:  2022-03-09       Impact factor: 4.599

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.